Hospital Israelita Albert Einstein
Clinical trials sponsored by Hospital Israelita Albert Einstein, explained in plain language.
-
New hope for sickle cell cure: High-Dose drug trial aims to unlock gene therapy
Disease control Not yet recruitingThis study is testing if a high dose of a drug called plerixafor can safely and effectively collect enough stem cells from people with sickle cell disease. These collected cells are a necessary first step for future gene therapy treatments, which aim to correct the disease at its…
Phase: PHASE1, PHASE2 • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Texts vs. calls: the race to connect ER patients with virtual doctors
Disease control Not yet recruitingThis study aims to reduce emergency room overcrowding by improving how patients connect with doctors after being sent home. It will test if sending text and email reminders, in addition to a phone call, helps patients contact a telemedicine team faster to discuss their lab result…
Phase: NA • Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Major study follows sepsis survivors for one year to map recovery journey
Knowledge-focused Not yet recruitingThis study aims to understand what happens to sepsis patients after they leave the hospital. Researchers will follow 760 adult patients in Brazil for one year after their hospital stay to track survival rates, hospital readmissions, quality of life, and cognitive function. This i…
Sponsor: Hospital Israelita Albert Einstein • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC